The U.S. health regulator has issued a warning letter to Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active pharmaceutical ingredients (APIs) plant. The U.S. Food and Drug Administration (USFDA) identified deviations from Current Good Manufacturing Practice for APIs during inspections on multiple dates in 2024. The company must address the deficiencies within 15 working days to prevent further regulatory action and ensure compliance with CGMP requirements.
Full Article
Karnataka 2nd PUC Exam 3 result 2025 declared, only 22% students pass
KSEAB has announced the Karnataka 2nd PUC Exam results for 2025, revealing a pass rate of only 22% among 82,683 candidates, though over 11,900 students improved their scores compared to 7,420 last year. Results will be available online from 1 PM on July 1, with an overall consolidated pass rate of 79.81%, as 5,66,636 out of 7,09,968 students passed, including repeaters and private candidates. Explain It To Me Like I'm 5: Karnataka's 2nd PUC Exam...
Read more